Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, View ORCID ProfileJacques Turgeon
doi: https://doi.org/10.1101/2020.04.21.20066761
Veronique Michaud
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Operating Officer
Pamela Dow
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
MSRoles: Clinical Research Manager
Sweilem B. Al Rihani
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmD, PhDRoles: Clinical Research Scientist
Malavika Deodhar
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Clinical Research Scientist
Meghan Arwood
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmDRoles: Clinical Research Scientist
Brian Cicali
2University of Florida Center for Pharmacometrics and Systems Pharmacology, 6550 Sanger Road, Orlando, FL 32827
MScRoles: PhD Student, Pharmaceutics
Jacques Turgeon
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Scientific Officer
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials.
Posted April 29, 2020.
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)